Millions of people now use artificial intelligence chatbots to seek health information online. In response, Microsoft and Mayo Clinic have launched a major partnership to develop an AI model trained specifically on healthcare data, medical research and clinical expertise. The project aims to address concerns about the reliability of health advice generated by mainstream AI systems. Most popular chatbots rely on broad internet content, which can sometimes produce inaccurate or unsafe responses. Microsoft unveiled the initiative during its Build developer conference. The project marks one of the industry’s most ambitious attempts to create a healthcare-focused AI system for both patients and medical professionals. “We needed to have the right data and the right people in the right place to be able to do this, and we firmly believe that will result in better healthcare outcomes for people who use the model,” Mayo Clinic CEO Gianrico Farrugia told CNN ahead of the announcement. Built on Medical Expertise and Clinical Data The new model differs from general-purpose AI chatbots. It will use Mayo Clinic’s extensive medical records, research findings and clinical expertise to generate responses. Mayo Clinic will own the model. Microsoft will provide AI technology and cloud computing support. The organizations plan to deploy the system first within Mayo Clinic’s healthcare network. Clinicians will test the technology and help improve its performance before a wider rollout. The partnership could eventually support AI tools across Mayo Clinic hospitals. The organizations may also license the technology to other healthcare providers. They also plan to create an AI healthcare assistant for patients. Users could access it through Mayo Clinic’s online portal. According to Microsoft AI CEO Mustafa Suleyman, the technology could help patients understand diagnoses, explore treatment options and learn more about preventive care. However, Suleyman warned that public deployment will take time. “It will take many years” to train and refine the model to a level where people can trust it for high-stakes health decisions, he said. The announcement comes as technology companies compete aggressively in the growing AI healthcare market. Studies published in journals such as Nature Medicine show that advanced AI systems perform well on some medical benchmarks. However, researchers continue to warn about inaccuracies, hallucinations and bias. Competition Intensifies in AI Healthcare Race Microsoft and Mayo Clinic’s move follows similar healthcare efforts by major technology firms. Google recently expanded its AI health tools. OpenAI and Anthropic have also added health-related features to their platforms. Mayo Clinic believes its clinical experience could provide a competitive advantage. The institution has already developed AI systems that help detect heart disease and assist with pancreatic cancer diagnosis. The healthcare provider said it anonymized patient data before using it for AI training. The two organizations declined to reveal the project’s financial details. Suleyman said both sides were making “very material, long-term commitments to one another.” Farrugia acknowledged concerns about artificial intelligence. However, he said healthcare systems around the world need innovative solutions to meet growing demand. “Globally, but even United States, there’s still so much need for better healthcare that we should embrace AI,” he said, “because it helps us get better results.” As interest in AI-powered health advice grows, Microsoft and Mayo Clinic hope their model can deliver more reliable and medically grounded guidance for patients and healthcare professionals.
The Future of Health Care Payments: AI, Insurance, and Patient Costs in 2026
Artificial intelligence isn’t just a buzzword anymore. It’s rapidly becoming a line item on healthcare budgets and insurance claims as 2026 dawns. But a big question looms: who should pick up the tab for AI tools that promise smarter, faster, and more accurate care? One concrete milestone is already here. Starting this month, U.S. Medicare will reimburse doctors over $1,000 for using an AI tool that analyzes coronary plaque, setting a national rate under the American Medical Association’s coding system. This move marks one of the first times AI has been given a formal, fee-for-service payment structure in medicine and experts say it could shape how future AI tools are valued and paid for. The stakes are high. AI in healthcare isn’t a fringe tech anymore. It’s embedded in everyday diagnostics, clinical decision support, drug discovery, and hospital workflows. Globally, the market for AI in health care is forecasted to surge from roughly $39 billion in 2025 to over $500 billion by 2032, meaning insurers, government payers, and hospitals will need clear rules on coverage and billing. Three payment trends are quickly emerging in 2026: Insurance Embracing Clinical AI: Payers like Medicare are beginning to put real numbers on AI services, encouraging clinicians to use technology that improves efficiency and outcomes. These reimbursement codes could be a tipping point for broader adoption. Outcome-Based Models: Beyond simple fee-for-service rates, policymakers are exploring value-based care arrangements where AI tools that demonstrably reduce costs and improve patient results may be rewarded financially. This represents a shift toward paying for results rather than activity. Employer and Private Payer Innovation: With rising premiums and cost pressures, self-insured employers and private insurers are experimenting with models that share financial risk and reward — especially when AI tools help reduce avoidable hospital visits or administrative waste. On top of payment dynamics, the technology itself is scaling. AI tools now assist with early disease detection, predictive analytics, and streamlined documentation, reshaping clinical workflows and cutting patient wait times. But cost and ethical concerns remain, including how to ensure equitable access and avoid driving up healthcare expenses without clear benefit. In 2026, the AI-healthcare intersection is no longer theoretical. It’s a practical and financial reality. The coming years will likely define new ground rules for how, and who, pays for technology that could be as transformative as antibiotics or vaccines once were.
